Literature DB >> 10050078

VCAM-1, ICAM-1, and E-selectin in IgA nephropathy and Schönlein-Henoch syndrome: differences between tissue expression and serum concentration.

C Mrowka1, B Heintz, H G Sieberth.   

Abstract

The tissue expressions of vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1) and endothelial leukocyte adhesion molecule 1 (E-selectin-1) were investigated in biopsy specimens from 28 patients with different stages of IgA nephropathy (IgAN) and 20 patients with acute renal failure (ARF) or chronic renal diseases (amyloidosis, Alport's glomerulopathy) by immunohistochemistry. The results were compared with the serum levels of the three adhesion molecules. VCAM-1 expression was significantly increased on parietal/tubular epithelial cells in IgAN and ARF. Significantly elevated circulating VCAM-1 levels were measured in IgAN and amyloidosis, but did not correlate with renal function (creatinine clearance). Significantly increased glomerular endothelial/epithelial ICAM-1 expression was found in IgAN and ARF. Intense mesangial ICAM-1 expression was found in mild stages of IgAN and in Schönlein-Henoch syndrome. Circulating ICAM-1 was not significantly elevated in IgAN and different renal diseases. VCAM-1 and ICAM-1 expressions of interstitial infiltrating cells were significantly higher in severe than in mild IgAN and associated with an increased infiltration of inflammatory leukocytes. Patients with IgAN and different renal diseases had decreased mesangial and almost absent interstitial E-selectin expression as compared with controls. The circulating E-selectin levels were significantly elevated in ARF. In conclusion, the tissue expression of adhesion molecules in IgAN reflects a continuous inflammatory renal activity. However, only increased circulating VCAM-1 serum levels correlated significantly with the histological state of renal inflammation and could be used as a disease marker.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10050078     DOI: 10.1159/000045290

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Plasma and urinary soluble adhesion molecule expression is increased during first documented acute pyelonephritis.

Authors:  R A Gbadegesin; S A Cotton; B M Coupes; A Awan; P E C Brenchley; N J A Webb
Journal:  Arch Dis Child       Date:  2002-03       Impact factor: 3.791

2.  Impaired vascular endothelium-dependent relaxation in Henoch-Schönlein purpura.

Authors:  Shunji Kurotobi; Nobuhiro Kawakami; Atsuko Honda; Taro Matsuoka; Tatsuyuki Hara; Toshisaburo Nagai; Kazuo Shimizu; Keiichi Ozono
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

3.  Pathogenesis-related adhesion molecules in Henoch-Schonlein vasculitis.

Authors:  Faysal Gok; Yesim Ugur; Seza Ozen; Attila Dagdeviren
Journal:  Rheumatol Int       Date:  2007-08-15       Impact factor: 2.631

4.  Albuminuria is associated with elevated acute phase reactants and proinflammatory markers in HIV-infected patients receiving suppressive combination antiretroviral therapy.

Authors:  Pichaya O-charoen; Lishomwa C Ndhlovu; Louie Mar A Gangcuangco; Sheila M Keating; Philip J Norris; Roland C K Ng; Brooks I Mitchell; Cecilia M Shikuma; Dominic C Chow
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12       Impact factor: 2.205

5.  Endothelial function in children with a history of henoch schonlein purpura.

Authors:  Yonatan Butbul Aviel; Lotem Dafna; Giora Pilar; Riva Brik
Journal:  Pediatr Rheumatol Online J       Date:  2017-01-14       Impact factor: 3.054

6.  Number and function of peripheral blood endothelial progenitor cells in Henoch-Schönlein purpura nephritis children with different degrees of renal vascular lesions.

Authors:  Xi-Qiang Dang; Xiao-Jie He; Hai-Xia Chen; Qing-Nan He; Zhu-Wen Yi
Journal:  Exp Ther Med       Date:  2012-12-18       Impact factor: 2.447

7.  Increased plasma sVCAM-1 is associated with severity in IgA nephropathy.

Authors:  Li Zhu; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  BMC Nephrol       Date:  2013-01-22       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.